NCT01126034

Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 85 (actual)
• Sponsor: University of Pennsylvania · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

The investigators hypothesized that: 1\) an intervention targeted at the prescribing physician would increase the rate of a metoclopramide discontinuation among patients prescribed the medication for questionable or unclear indications; and 2) the discontinuation would be durable.

Conditions

• Gastroesophageal Reflux Disease
• Diabetic Gastroparesis

Interventions

Type	Name	Description
OTHER	intervention letter	Physicians in the intervention group were mailed a written feedback letter regarding their patients who were prescribed questionable metoclopramide therapy. Non-intervention providers received no letter. The letter consisted of the following components: 1. The name and medical record # of the patients involved 2. Information regarding the metoclopramide prescription: dates, dosage, indication recorded, and the duration of therapy 3. A reminder of the adverse effect of long-term metoclopramide therapy 4. A recommendation to consider having the patient undergo a trial of metoclopramide discontinuation if appropriate, and documentation of a discussion of risk and benefits of metoclopramide therapy with patients 5. A request that the physician document the discontinuation trial in the electronic medical record

Timeline

• Start date: 2007-03-01
• Primary completion: 2008-04-01
• Completion: 2008-04-01
• First posted: 2010-05-19
• Last updated: 2015-12-04

Locations

1 site across 1 country: United States